Posts

Tumor biomarkers for diagnosis, prognosis and targeted therapy | Signal Transduction and Targeted Therapy

Image
thyroid cancer guidelines :: Article Creator Experts Debate Benefits And Challenges Of New ATA Guidelines And Differentiated Thyroid Cancer Just a moment... This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and Hold Press and hold the button If you believe this is an error, please contact our support team. 167.71.87.121 : 32898e3d-1954-45a1-9662-255ceec5 New Clinical Guidelines For Thyroid Disease Management The announcement that new clinical practice guidelines for the diagnosis and treatment of hypothyroidism are published in the current issue of Thyroid was made by The American Thyroid Association (ATA). The Guidelines were developed jointly by the ATA and the American Association of Clinical Endocrinologists (AACE) and will be presented on Sunday, Sept. 23, during the 82nd Annual Mee...

FDA's July 2024 Roundup: Breakthroughs and Milestones in Cancer Treatment

Image
pulmonologist st joseph :: Article Creator Dr. Anton Manyak, MD Dr. Anton Manyak, MD works in Tacoma, WA as a Pulmonologist.At present, Dr. Manyak has received an average rating of 5.0 from patients and has been reviewed 1 times. Dr. Manyak is affiliated with St. Joseph Medical Center. Dr. Manyak is accepting new patients. Dr. Manyak also speaks Russian. Dr. Manyak practices at Franciscan Pulmonary Associates at St. Joseph in Tacoma, WA. Explains Conditions Well Patients said this doctor explains conditions well. Dr. Brian Reichardt, MD Dr. Brian Reichardt, MD works in O Fallon, IL as a Pulmonologist.Dr. Reichardt is board certified in Critical Care Medicine and graduated from Ross University School of Medicine. Dr. Reichardt has has worked on more claims relating to Emphysema and Bronchitis than other providers in the area. At present, Dr. Reichardt has received an average rating of 4.2 from patients and has been reviewed 10 times. Dr. R...

A blood test to detect cancer? Some patients are using them already.

Image
signs of penile cancer :: Article Creator 'I Had Let It Go Too Far ... But I Had Zero Pain': We Need To Talk About Penile Cancer It took a knee injury while running the Dublin City Marathon in 2019 to get Cormac France to his GP about an issue with his penis. He used the knee as a "cover up", he says, out of embarrassment when making the appointment over the phone. But once in the consultation room, "I said, 'now doctor, can I tell you the real reason I'm here, I need to show you something'…" For many months the father of four had been aware of a "horrible smell" from his nether regions, but had put it down to his tendency after a run to change his sweat-soaked tops as soon as he returned to his home in Leixlip, Co Kildare, but to leave the lower clothes on. He thought this had caused the drying out of skin, but then it got so bad, his penis split, "like lightning hitting the tree", he ...

Molecular Diagnostics in Clinical Oncology

Image
t4n1m0 lung cancer :: Article Creator

Cancer Ribbon Colors, Meanings, and Months

Image
acute myeloid leukemia causes :: Article Creator Studies Examine Real-World Pediatric AML Treatment And Outcomes Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients treated for pediatric acute myeloid leukemia (AML). At the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition, research on real-world treatment and outcomes for patients with pediatric acute myeloid leukemia (AML) added to the understanding of clinical trial outcomes. Highlights included posters exploring the role of allogeneic hematopoietic cell transplantation (allo-HSCT) in treating pediatric AML, along with updates from APAL2020SC (NCT04726241), an ongoing Leukemia and Lymphoma Society-sponsored screening trial and registry for patients with relapsed or refractory acute leukemias. A retrospective analysis using data from the AML-BFM trials conducted in 2004 and 2012 and the AML-BFM 2012 reg...

A blood test to detect cancer? Some patients are using them already.

Image
ovarian clear cell carcinoma :: Article Creator Global Trends In Ovarian Cancer Incidence Highlight Regional, Histological Variations Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors. Variations in global patterns and trends of ovarian cancer (OC) incidence and its subtypes were observed between 1988 and 2017, with potential influence from genetic and reproductive factors, according to a study published in eClinicalMedicine.1 Despite declining OC incidence rates over the past few decades, particularly in high-income countries, OC prognosis remains dismal, with age-standardized 5-year net survival rates varying between 30% and 50% in most countries.2 However, only 3 studies have investigated the global patterns or trends of OC incidence, both overall and by histological subtype.1 Due to the limited scope of th...

Molecular Diagnostics in Clinical Oncology

Image
small cell lung carcinoma treatment :: Article Creator Top 10 Lung Cancer Advances Of 2024 Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical trial results. Lung cancer: © Crystal Light - stock.Adobe.Com Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical trial results. Here are some of the top developments covered by Targeted OncologyTM, highlighting the progress in targeted therapies and improved patient outcomes. FDA Approval of Ensartinib for ALK-Positive NSCLC: The FDA approved ensartinib for the first-line treatment of patients with ALK-positive locally advanced or metastatic non–small cell lung cancer (NSCLC) who have not previously received an ALK inhibitor. This decision was supported by findings from the phase 3 eXalt3 trial (NCT02767804), which demonstrated a median progression-fr...